Search for: "Michael Reddy"
Results 21 - 40
of 62
Sorted by Relevance
|
Sort by Date
26 May 2023, 6:30 am
Reddy (University of Cambridge) , on Tuesday, May 23, 2023 Tags: Equity offerings, Financial institutions, Financial regulation, investors, London Stock Exchange, Monetary policy Navigating the Current ESG Landscape: Recommendations for the Board and Management Posted by Martin Lipton, Wachtell Lipton Rosen & Katz, on Tuesday, May 23, 2023 Tags: anti-ESG, Board of Directors, ESG, ESG risks, Fiduciary duties, Management, strategy Importance of Special Litigation Committees in… [read post]
27 Apr 2010, 10:58 pm
(Patent Docs) Prilosec (Omeprazole) – US: Dr Reddy’s wins attorney’s fees from AstraZeneca in Prilosec OTC case (Orange Book Blog) Protonix (Pantoprazole) – US: Jury finds Protonix patent infringed by Teva (The IP Factor) Restasis (Ciclosporin) – Restasis royalty dispute finally settles (IP finance) Tarceva (Erlotinib) – India: Roche and Tarceva in Delhi HC again, this time vs Natco (Spicy IP) (Generic Pharmaceuticals and IP) Viagra (Sildenafil) –… [read post]
11 Dec 2008, 10:30 pm
Reddy's Laboratories, Ltd. [read post]
21 Sep 2009, 12:49 pm
Apollo Hospitals MD Preetha Reddy said for the moment things are still at a lucid stage. [read post]
21 Sep 2009, 12:49 pm
Apollo Hospitals MD Preetha Reddy said for the moment things are still at a lucid stage. [read post]
29 Jun 2012, 9:06 am
Per curiam: PDF Michael B. [read post]
10 Dec 2008, 10:15 pm
In 2005, Michael H. [read post]
16 May 2017, 7:01 am
The discussion will be moderated by Michael Crowley from Politico. [read post]
20 Mar 2009, 6:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Reps Eshoo, Inslee and Barton introduce Pathway for Biosimilars Act (FDA Law Blog) (Patent Docs) (Patent Baristas) (Patent Baristas) (Law360) US: Reps Waxman, Pallone, Deal and Emerson introduce Promoting Innovation and Access to Life-Saving Medicine Act (Intellectual Property Watch) (IPKat) (Patent Docs) EU: Pharma submissions relating to… [read post]
15 Mar 2024, 3:17 am
Law professors Joshua Davis and Anupama Reddy suggest algorithms might provide DOJ clearer trails to litigate such collusive schemes. [read post]
8 Sep 2007, 7:14 am
--Sanjay Reddy, Columbia UniversityAs one would expect from Unger, the book is brilliantly written and his central theses are persuasively and passionately argued. [read post]
29 Jan 2010, 12:58 am
BONILLA; With Sumathi Reddy denise.bonilla@newsday.com... [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
25 Jul 2008, 7:04 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC affirms validity and enforceability of Eisai’s compound patent on Aciphex; elucidates current standard for obviousness of chemical composition of matter patents: Eisai v Reddy’s Lab’s and Teva Pharma: (Orange Book Blog), (Patent Docs), (Patent Prospector), (IP Law360), (Hal Wegner), (Patent Baristas),… [read post]
7 Apr 2010, 4:30 am
(The SPC Blog) (IPKat) Great Indian paradox – India preparing to challenge EU regulations at WTO while also attempting to seal Indo-EU FTA (Spicy IP) (Michael Geist) Risk of wrongful medicines seizures seen in EU-Central America trade deal (IP Watch) General Unbiased HIV patent pool: A free-market, middle-income countries open model (IP Watch) World’s leading life science patent litigation law firms revealed (IAM) British official to lead International Union for the… [read post]
1 Oct 2021, 5:54 am
McLeod, and Anitha Reddy, Wachtell, Lipton, Rosen & Katz, on Tuesday, September 28, 2021 Tags: Boards of Directors, Delaware cases, Delaware law, Derivative suits, Dual-class stock, Facebook, Securities litigation, Shareholder suits Remarks by Commissioner Peirce Before the Small Business Capital Formation Advisory Committee Posted by Hester M. [read post]
6 Apr 2019, 9:46 am
Finally, Rose reports on a new question of double-patenting being referred to the Enlarged Board of Appeal (EBA).Michael Burdon shares his opinion about the role of the English courts in FRAND determinations in the absence of a dispute resolution mechanism in SSOs.Trade marksPeter Ling discusses a recent decision rendered by the US Court of Appeals for the Fourth Circuit in relation to registration of the trade mark “BOOKING.COM". [read post]
18 Dec 2020, 10:55 am
By Ilhyung Lee (University of Bristol), Metatags ‘using’ third party trade marks on the Internet by David Llewelyn (King’s College London) and Prashant Reddy(NALSAR), Keyword advertising and actionable consumer confusion by Robert Burrell (University of Oxford) and Michael Handler and Fit for purpose? [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences:… [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade Representative over Special 301… [read post]
